Comparative evaluation of nerve repair and local tissue response following ReFeel<sup>®</sup> nerve cuff implantation in a rat sciatic model
Russell TA., Tzagiollari A., Doherty BO., Burke O., Duffy S., Dorrell P.
Animal Study on Chronic Inflammation, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Front Bioeng Biotechnol (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42110312
- PMCID
- PMC13150485
- DOI
- 10.3389/fbioe.2026.1759129
Abstract (original English)
Introduction Peripheral nerve injuries (PNIs) pose a persistent clinical challenge, with current repair strategies limited by material biocompatibility, degradation, and regenerative efficacy. This study evaluates the in vivo performance of ReFeel®, a novel bioresorbable alginate-polyglycolic acid (PGA) nerve cuff, in two rat sciatic nerve models, compared to commercial collagen-based repair devices NeuroMatrix® (conduit) and NeuroMend® (wrap). Methods Two studies were conducted in Sprague-Dawley rats using either a 10 mm sciatic nerve gap model (ReFeel® vs. NeuroMatrix®) or a no-gap intact sciatic nerve perineural wrap model (nerve exposed but not transected), comparing ReFeel® with NeuroMend®. Functional, histological, immunohistochemical, and morphometric assessments were performed at 1 week, 8 weeks, and 26 weeks (gap model) and 1 week, 8 weeks, and 13 weeks (wrap model). Tissues were analyzed using hematoxylin and eosin (H&E), Masson's trichrome, Safranin-O, NF200, S-100, and toluidine blue staining. Degradation, host response, axon regeneration, Schwann cell activity, and fibrosis were quantified. Results ReFeel® demonstrated superior Schwann cell alignment and axonal regeneration, particularly at 26 weeks, with near-complete scaffold resorption and minimal fibrotic encapsulation. Quantitative scores showed higher axon densities and comparable G-ratios versus NeuroMatrix®
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Comparing Regenerative Biologics and Standard Pharmacotherapy for Chronic Rotator Cuff Tendinopathy: A Study of PRP, Cell-Based, and Peptide Interventions
Systematic Review on Tendon Injury, Rotator Cuff, Shoulder Pain, Chronic Inflammation, published in J Orthop Sports Med (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Sports Med - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level ASystematic ReviewEurope PMC
Exosomes as Cellular Communicators and Therapeutic Agents in Orthopedic Diseases: From Mechanisms to Intervention
Systematic Review on Osteoarthritis, Chronic Inflammation, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.
- 2026
Int J Nanomedicine1 citations - Level ASystematic ReviewEurope PMC
Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review
Systematic Review on Chronic Inflammation, Immune Modulation, published in Front Oncol (2026) — summary generated from the PubMed abstract.
- 2026
Front Oncol - Level ASystematic ReviewEurope PMC
Trends in peripheral nerve injury research: a bibliometric analysis focused on molecular mechanisms
Systematic Review on Chronic Inflammation, published in Front Neurol (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurol